Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

January 31, 2004

Study Completion Date

February 29, 2004

Conditions
Healthy
Interventions
DRUG

Ondansetron

ODT, single-dose, fasting

DRUG

Zofran

ODT, single-dose, fasting

Trial Locations (1)

H7V 4B4

Algorithme Pharma, Laval

Sponsors
All Listed Sponsors
collaborator

Algorithme Pharma Inc

INDUSTRY

lead

Par Pharmaceutical, Inc.

INDUSTRY